Home/Filings/4/0001358403-17-000129
4//SEC Filing

BELLICUM PHARMACEUTICALS, INC 4

Accession 0001358403-17-000129

CIK 0001358403operating

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 4:09 PM ET

Size

5.5 KB

Accession

0001358403-17-000129

Insider Transaction Report

Form 4
Period: 2017-07-03
Musso Alan A
CFO and Treasurer
Transactions
  • Award

    Stock Option (right to buy)

    2017-07-03+31,50031,500 total
    Exercise: $11.70Exp: 2027-07-02Common Stock (31,500 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the stock option vest and become exercisable on January 1, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeoperating

Related Parties

1
  • filerCIK 0001358403

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:09 PM ET
Size
5.5 KB